Provided by Tiger Fintech (Singapore) Pte. Ltd.

SeaStar Medical Holding Corporation

0.3614
-0.0187-4.92%
Volume:451.28K
Turnover:167.92K
Market Cap:13.03M
PE:-0.18
High:0.3954
Open:0.3954
Low:0.3600
Close:0.3801
52wk High:3.07
52wk Low:0.3054
Shares:36.05M
Float Shares:33.83M
Volume Ratio:2.00
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0246
EPS(LYR):-6.6327
ROE:--
ROA:-156.15%
PB:3.90
PE(LYR):-0.05

Loading ...

Company Profile

Company Name:
SeaStar Medical Holding Corporation
Exchange:
NASDAQ
Establishment Date:
2007
Employees:
19
Office Location:
3513 Brighton Boulevard,Suite 410,Denver,Colorado,United States
Zip Code:
80216
Fax:
- -
Introduction:
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver, Colorado.

Directors

Name
Position
Eric Schlorff
Chief Executive Officer and Director, Principal Financial Officer, Interim Chief Financial Officer and Treasurer
Jennifer A. Baird
Chairman
Bernadette N. Vincent
Independent Director
Kenneth Van Heel
Independent Director
John Neuman
Director

Shareholders

Name
Position
Eric Schlorff
Chief Executive Officer and Director, Principal Financial Officer, Interim Chief Financial Officer and Treasurer
Bradford Towne
Controller, Principal Accounting Officer
Kevin Chung
Chief Medical Officer